The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Coronary microvascular dysfunction in the clinical setting: from mystery to reality
Open accessAbstract
Far more extensive than the epicardial coronary vasculature that can be visualized angiographically is the coronary microcirculation, which foregoes routine imaging. Probably due to the lack of techniques able to provide tangible evidence of its crucial role, the clinical importance of coronary microvascular dysfunction is not fully appreciated. However, evidence gathered over the last several decades indicates that both functional and structural abnormalities of the coronary microvasculature can lead to myocardial ischaemia, often comparable with that caused by obstructive coronary artery disease. Indeed, a marked increase in coronary microvascular resistance can impair coronary blood flow and trigger angina pectoris, ischaemic ECG shifts, and myocardial perfusion defects, and lead to left ventricular dysfunction in patients who otherwise have patent epicardial coronary arteries. This condition--often referred to as 'chest pain with normal coronary arteries' or 'cardiac syndrome X'--encompasses several pathogenic mechanisms involving the coronary microcirculation. Of importance, coronary microvascular dysfunction can occur in conjunction with several other cardiac disease processes. In this article, we review the pathogenic mechanisms leading to coronary microvascular dysfunction and its diagnostic assessment, as well as the different clinical presentations and prognostic implications of microvascular angina. As such, this review aims to remove at least some of the mystery surrounding the notion of coronary microvascular dysfunction and to show why it represents a true clinical entity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prognostic Value of Coronary Vascular Endothelial Dysfunction
Halcox, J. P. J., Schenke, W. H., Zalos, G., Mincemoyer, R., Prasad, A., Waclawiw, M. A., Nour, K. R. A., & Quyyumi, A. A. (2002) · Circulation · doi:10.1161/01.cir.0000025404.78001.d8 · Cited by 1,385 · cited 1×
“higher risk of developing cardiovascular events during follow-up, regardless of the presence or absence of obstructive epicardial coronary artery stenoses.(86,87) With the caveats outlined above, an abnormal CFR seems to be a marker of a worse long-term outcome including a .”
BackgroundEffects of cardiac sympathetic innervation on coronary blood flow
Di Carli, M. F., Tobes, M. C., Mangner, T., Levine, A. B., Muzik, O., Chakroborty, P., & Levine, T. B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361703 · Cited by 237
Schindler, T. H., Nitzsche, E. U., Schelbert, H. R., Olschewski, M., Sayre, J., Mix, M., Brink, I., Zhang, X.-L., Kreissl, M., Magosaki, N., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.040 · Cited by 149 · cited 1×
“While it may be argued that the extent of CAD was not taken into consideration in these studies, an abnormal MBF response to cold pressure testing predicted a 6–8 times higher incidence of ACS and revascularization events during long-term follow-up even in patients without luminal irregularities on angiography.(92)”
Background
Cited by
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000133 · Cited by 1,254
Cardiovascular Disease in Women: Clinical Perspectives
Garcia, M., Mulvagh, S. L., Bairey Merz, C. N., Buring, J. E., & Manson, J. E. (2016) · Circulation Research · doi:10.1161/circresaha.116.307547 · Cited by 1,080
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000134 · Cited by 1,059
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.016 · Cited by 777
Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
(2016) · European Heart Journal · doi:10.1093/eurheartj/ehv598 · Cited by 739
Herrmann, J., Lenihan, D., Armenian, S., Barac, A., Blaes, A., Cardinale, D., Carver, J., Dent, S., Ky, B., Lyon, A. R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab674 · Cited by 645
Self-citationKaski, J.-C., Crea, F., Gersh, B. J., & Camici, P. G. (2018) · Circulation · doi:10.1161/circulationaha.118.031373 · Cited by 340
Self-citationCoronary Microvascular Dysfunction
Vancheri, F., Longo, G., Vancheri, S., & Henein, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092880 · Cited by 321
Coronary Microvascular Dysfunction, Microvascular Angina, and Treatment Strategies
Marinescu, M. A., Löffler, A. I., Ouellette, M., Smith, L., Kramer, C. M., & Bourque, J. M. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2014.12.008 · Cited by 302
Regulation of Coronary Blood Flow in Health and Ischemic Heart Disease
Duncker, D. J., Koller, A., Merkus, D., & Canty, J. M. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2014.12.002 · Cited by 255
Metadata
- Authors
- Herrmann, J., Kaski, J. C., & Lerman, A.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-22
- Volume
- 33
- Issue
- 22
- Pages
- 2771-2783
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2103901552
- Cited by
- 227
- References
- 3
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.